Oral Session 2-13C MDS：Basic (2)

[OS2-13C-2] Prevalence of germline SAMD9/9L variants in pediatric hematological disorders with monosomy 7

Masanori Yoshida^1,2, Kanako Nakao³, Hirohito Shima³, Ryota Shirai^1,2, Kaoru Yoshida¹, Shinichi Tsujimoto^1,2, Tomoo Osumi^1,4, Takao Deguchi⁴, Makiko Mori⁵, Yuki Arakawa⁵, Masatoshi Takagi⁶, Takako Miyamura⁷, Kimiyoshi Sakaguchi⁸, Hidemi Toyoda⁹, Hisashi Ishida¹⁰, Naoki Sakata¹¹, Toshihiko Imamura¹², Yuta Kawahara¹³, Takashi Koike¹⁴, Daisuke Tomizawa⁴, Nobutaka Kiyokawa¹, Satoshi Narumi³, Motohiro Kato^1,4 (1.Department of Pediatric Hematology and Oncology Research, NCCHD, Tokyo, Japan, 2.Department of Pediatrics, Yokohama City University, 3.Department of Molecular Endocrinology, NCCHD, Tokyo, Japan, 4.Children's Cancer Center, NCCHD, Tokyo, Japan, 5.Department of Hematology/Oncology, SCMC, Saitama, Japan, 6.Department of Pediatrics, Tokyo Medical Dental University, Tokyo, Japan, 7.Department of Pediatrics, Osaka University, Osaka, Japan, 8.Pediatrics, Hamamatsu University School of Medicine, Shizuoka, Japan, 9.Pediatrics, Mie University, Mie, Japan, 10.Department of Pediatrics, Okayama University Hospital, Okayama, Japan, 11.Departments of Pediatrics, Kindai University Faculty of Medicine, Osaka, Japan, 12.Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 13.Department of Pediatrics, Jichi Medical University, 14.Department of Pediatrics, Tokai University School of Medicine, Kanagawa, Japan)